(Q58411051)

Magnus Kaijser

12

0 references

Hans H Storm

Hans Storm

6

0 references

Per Hall

7

Per Hall

0 references

Timo Joensuu

14

Timo Joensuu

0 references

Sophie D. Fosså

2

Sophie D. Fosså

0 references

Lois B. Travis

1

Lois B. Travis

0 references

author name string

Sara J. Schonfeld

3

0 references

Mary L. McMaster

4

0 references

Charles F. Lynch

5

0 references

Eric Holowaty

8

0 references

Aage Andersen

9

0 references

Michael Andersson

11

0 references

Mary Gospodarowicz

13

0 references

Randi J. Cohen

15

0 references

John D. Boice

16

0 references

Graça M. Dores

17

0 references

Ethel S. Gilbert

Journal of the National Cancer Institute

18

0 references

language of work or name

English

0 references

publication date

21 September 2005

0 references

published in

0 references

volume

97

0 references

issue

18

0 references

page(s)

1354-1365

0 references

cites work

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Mortality after cure of testicular seminoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Incidence of second primary cancer following testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Tissue doses from radiotherapy of cancer of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

The use of drugs in combination for the treatment of cancer: rationale and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Lung cancer in radon-exposed miners and estimation of risk from indoor exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Variations with time and age in the risks of solid cancer incidence after radiation exposure in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Simple exact analysis of the standardised mortality ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Definition and estimation of lifetime detriment from radiation exposures: principles and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Second non-germ cell malignancies in patients treated for stage I–II testicular seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Radiation dose and second cancer risk in patients treated for cancer of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Malignant neoplasms after radiation therapy for peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Treatment-Associated Leukemia Following Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

21 January 2018

Carcinoma of the testis

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Lung cancer after treatment for Hodgkin's disease: focus on radiation effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Lifestyle issues and genitourinary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Therapy-associated solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Treatment of testicular cancer and the development of secondary malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Long-term medical care of testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

American Cancer Society guidelines for the early detection of cancer, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI278